MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-11-2026
Stryker Corporation Cash Conversion Cycle 2011-2026 | SYK
Annual Cash Conversion Cycle Stryker Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 337 | 364 | 210 | 192 | 206 | 254 | 254 | 243 | 234 | 215 | 195 | 199 | 197 | 189 | 184 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 364 | 184 | 232 |
Quarterly Cash Conversion Cycle Stryker Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 217 | 216 | 223 | 239 | 231 | 235 | 239 | 216 | 208 | - | 103 | 97.2 | 201 | 56.7 | 213 | 215 | 232 | 57.8 | 258 | 291 | 252 | 63.9 | 263 | 260 | 250 | 56.1 | 259 | 250 | 241 | 57.8 | 243 | 66.6 | 64.3 | 56.9 | 63.4 | 63.2 | 66.4 | 55.9 | 62.7 | 62.4 | 62 | 54.8 | 60 | 60.7 | 61.2 | 56.1 | 64.4 | 62.6 | 61.4 | 55.8 | 63.6 | 62 | 60.1 | 58.4 | 63.7 | 63.2 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 291 | 54.8 | 136 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Align Technology
ALGN
|
137 | $ 176.83 | 5.97 % | $ 13.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 11.66 | 5.71 % | $ 1.75 B | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
AxoGen
AXGN
|
245 | $ 34.0 | 9.71 % | $ 1.57 B | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 12.18 | 2.01 % | $ 1.65 B | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
263 | $ 281.15 | 1.13 % | $ 7.93 B | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 38.25 | 4.31 % | $ 5.7 K | USA |
 |
GBS
GBS
|
204 | - | -0.57 % | $ 7.12 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 62.56 | 1.15 % | $ 92.6 B | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
180 | $ 24.4 | 2.61 % | $ 206 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.17 | 1.1 % | $ 260 M | USA |
 |
Globus Medical
GMED
|
314 | $ 91.96 | 2.13 % | $ 12.4 B | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
815 | $ 4.14 | 2.22 % | $ 876 M | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Nevro Corp.
NVRO
|
297 | - | - | $ 217 M | USA |
 |
Cytosorbents Corporation
CTSO
|
104 | $ 0.62 | 1.67 % | $ 38.6 M | USA |
 |
EDAP TMS S.A.
EDAP
|
136 | $ 3.37 | -0.88 % | $ 126 M |  France |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Delcath Systems
DCTH
|
258 | $ 9.85 | 1.86 % | $ 353 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 36.59 | 5.94 % | $ 1.14 B | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.62 | 0.22 % | $ 122 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 81.71 | 1.08 % | $ 47.8 B | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 53.38 | -1.89 % | $ 1.57 B | USA |
 |
Varex Imaging Corporation
VREX
|
211 | $ 11.04 | 4.25 % | $ 457 M | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.88 | 2.73 % | $ 1.14 M | USA |
 |
Inogen
INGN
|
48.9 | $ 6.67 | -1.91 % | $ 177 M | USA |
 |
IRIDEX Corporation
IRIX
|
105 | $ 1.03 | - | $ 17.4 M | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 87.48 | 2.78 % | $ 3.04 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 16.01 | 1.59 % | $ 376 M | USA |